- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Verve Therapeutics pumps in series A funding
GV led a $58.5m round for the heart disease drug developer, which is advancing research conducted at Harvard University and Broad Institute and has a partnership in place with Harvard spinout Beam Therapeutics.
May 9, 2019GenDx meets Ampersand for funding
UMC Utrecht molecular diagnostics spinout Genome Diagnostics has won funding from Ampersand Capital Partners and will work with the private equity firm to spur business growth through activities including M&A.
May 9, 2019LunaPBC glistens in $4.6m round
Osage University Partners has invested in LunaPBC, the public benefit corporation responsible for operating the community-owned LunaDNA genetic and health data collection platform.
May 9, 2019Brizzard moves on from IU’s ICO
Bill Brizzard will end his tenure as executive director of Indiana University’s Innovation and Commercialization Office to be replaced by Karen White on a temporary basis.
May 9, 2019Neural Analytics cognises $22m
UCLA spinout Neural Analytics increased its total funding to $66m as it prepares for further testing of its robotically-assisted brain health monitoring platform.
May 9, 2019MIT Solve sets sights on $30m fund
MIT-run social enterprise incubator MIT Solve is to gain an impact investment fund with a $30m target size to back participants in its annual Global Challenges innovation contest.
May 9, 2019Therachon certifies $810m acquisition
Pfizer will pay $340m upfront and up to an additional $470m in milestone payments to purchase its portfolio company Therachon, providing an exit to Inserm Transfert Initiative.
May 9, 2019Byton moves closer to $500m series C
FAW Group will reportedly provide $100m for TUS Holdings-backed Byton for a $500m round likely to value the electric SUV developer at more than $2.5bn.
May 8, 2019Promethera Biosciences fires its way to series D
UCL spinout Promethera Biosciences has increased its series D round to $44.4m with a $33.1m Mitsui and Medipal-backed extension, adding to Itochu’s initial investment earlier this year.
May 8, 2019Ciara draws seven-figure investment
Sales productivity software platform Ciara has won the backing of TUM-allied venture firm UVC Partners in a round that will support continued development of its software.
May 8, 2019SamanTree branches out with $9.3m
Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.
May 8, 2019Rfrnz reaches seven-digit understanding
TUM automated legal analysis spinout Rfrnz has secured backing from Unternehmertum-operated Initiative for Industrial Innovations, HTGF and unnamed additional investors.
May 8, 2019Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


